TDO/IDO inhibitors (NewLink/Genentech)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameTDO/IDO inhibitors (NewLink/Genentech)

Drug Alias Namedual IDO checkpoint inhibitor/TDO checkpoint inhibitor (NewLink/Genentech)dual tryptophan-2,3-dioxygenase/indoleamine-2,3-dioxygenase inhibitors (NewLink/Genentech)TDO/IDO inhibitors (NewLink)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTryptophan 2,3-dioxygenase inhibitorsIndoleamine 2,3-dioxygenase inhibitors

TargetsTryptophan 2,3-dioxygenaseIndoleamine 2,3-dioxygenase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusSuspended

Highest Status in ChinaN/A

Originator CompaniesLumos Pharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesLumos Pharma Inc

Inactive CompaniesGenentech Inc

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A